cBrain raises expected 2024 EBT margin to 30-32%

Seeking Alpha / 1 hour from now 1 Views

ProVen Growth and Income VCT plc: Issue of Equity

4 hours from now
RUBIS: Share buyback programme

4 hours from now
RUBIS: Programme de rachat d’actions

4 hours from now
Valneva Reports High Sustained Immune Response in Adolescents One Year After Single Vaccination with its Chikungunya Vaccine

4 hours from now
Valneva annonce une réponse immunitaire robuste et durable chez les adolescents un an après une seule vaccination avec son vaccin contre le chikungunya

4 hours from now